SKYW
核心业务

HK Capital Markets — Primary & Secondary

A licensed institution's perspective on China's new economy capitalization

Licensed under SFC Type 6 and Type 9, SkyW participates across the full Hong Kong capital markets cycle.

Primary Markets

SkyW acts as cornerstone and anchor investor in Hong Kong IPOs — providing not just capital, but institutional credibility signals that materially improve subscription rates and pricing stability. Recent participation spans: hard tech (Cambricon, UBTECH, Horizon Robotics), new consumption (Chow Sang Sang, Mixue, Guti), and healthcare (Insilico Medicine, Lepu Biopharma).

Secondary Markets

SkyW leverages deep primary market intelligence and Greater Bay Area industrial networks to identify mispriced opportunities in Hong Kong's technology and new economy sectors.

Value for International Investors

Co-participating in HK IPO cornerstone tranches through a licensed institution represents the most compliant and efficient entry point into China's new economy assets for Singapore family offices and Middle Eastern capital.

了解更多或洽谈合作机会

联系我们